GLP-1 receptor agonists (GLP-1RAs) like liraglutide and semaglutide, as well as the dual GLP-1 and gastric inhibitory polypeptide ... that can improve molecular functions and drug properties ...

a glucagon-like peptide-1 (GLP-1)/gastric inhibitory polypeptide (GIP), to treat obesity. The final output collection and quality control will be completed soon, with top-line data anticipated ...

Your body naturally produces the hormones GLP-1 and gastric inhibitory polypeptide receptor (GIP), known as incretin hormones. These hormones have several functions: In people with type 2 diabetes ...

Dr Paras Agarwal said that tirzepatide or semaglutide is mainly a sugar-reducing medicine which is given to diabetes patients but tirzepatide, which is sold as Mounjaro and Ozempic, activates the ...

Natural products industry companies share overviews on the latest science on their branded ingredients and products to ...

A California chef said "horrible stomach problems" led him to change his diet, find the kitchen and embrace the Make America Healthy Again movement. American Gravy restaurant group owner Andrew ...

Retatrutide, produced by Eli Lilly, also activates glucagon receptors, alongside GLP-1 receptors and gastric inhibitory polypeptide (GIP) receptors, which helps regulate blood glucose and nutrient ...

That feeling of fullness you get after a big meal comes not just from your stomach but your brain. Specifically it’s the pro-opiomelanocortin (POMC) neurons in the hypothalamus, which activate ...

Researchers have now discovered that what we call the 'dessert stomach' is rooted in the brain. The same nerve cells that make us feel full after a meal are also responsible for our craving for ...

Diabetic nephropathy Phase 2B study in patients with Type 2 diabetic nephropathy / reported positive and beneficial results for the majority of patients related to worsening kidney function and ...